المؤلفون: Ella Willenbacher, Zita Borbényi, Steffen Koschmieder, Robert Kralovics, Mario Cazzola, Uwe Platzbecker, Emanuil Gheorghita, Pencho Georgiev, Heinz Gisslinger, Mathieu Puyade, Malgorzata Calbecka, Jerome Rey, Kurt Krejcy, Jiri Mayer, Krzysztof Warzocha, Emilie Cayssials-Caylus, Veronika Buxhofer-Ausch, János Jakucs, Anna Vallova, Georgi Mihaylov, Hans Carl Hasselbalch, Lydia Roy, Vera Yablokova, Olga Cerna, Aleksander Skotnicki, Richard Greil, Jiri Schwarz, Vera Stoeva, Lylia Sivcheva, Zvenyslava Masliak, Halyna Pylypenko, Antonia Hatalova, Delia Dima, Jose Miguel Torregrosa-Diaz, Elena Volodicheva, Jean-Jacques Kiladjian, S V Klymenko, Carlos Besses Raebel, Polina Kaplan, Irina Sokolova, Horia Bumbea, Miklos Egyed, Nicoleta Berbec, Barbara Grohmann-Izay, Alexander Myasnikov, Petr Dulicek, Tamila Lysa, Dominik Wolf, Andrei Cucuianu, Christoph Klade, Mihaela Lazaroiu, Maria Soroka-Wojtaszko, Tamás Masszi, Ernst Forjan, Liana Gercheva-Kyuchukova, Franz Bauer, Dorota Krochmalczyk, Árpád Illés, Mikulas Hrubisko, Jolanta Starzak-Gwozdz, Viktor Rossiev

المصدر: The Lancet Haematology. 7:e196-e208

مصطلحات موضوعية: Male, medicine.medical_specialty, Polycythaemia, Equivalence Trials as Topic, Interferon alpha-2, Antiviral Agents, Polyethylene Glycols, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Humans, Medicine, Stage (cooking), Adverse effect, Polycythemia Vera, Aged, business.industry, Interferon-alpha, Hematology, Middle Aged, Prognosis, medicine.disease, Interim analysis, Recombinant Proteins, Clinical trial, Tolerability, 030220 oncology & carcinogenesis, Female, business, Follow-Up Studies, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef767894c3f5dbd8084e8e09eb738e2fTest
https://doi.org/10.1016/s2352-3026Test(19)30236-4

المؤلفون: Lionel Ades, Richard F. Schlenk, Oliver Tiebel, Katja Sockel, Katharina Götze, Jose Miguel Torregrosa Diaz, Anna Mies, Marie-Pierre Gourin, Marie-Luise Huetter-Kroenke, Katja Jersemann, Georgia Metzgeroth, Kamel Laribi, Uwe Platzbecker, Pierre Fenaux, Anna Jonasova, Rosa Sapena, Sophie Dimicoli-Salazar, Anne Sophie Kubasch, Christian Thiede, Fatiha Chermat, Pascale Cony-Makhoul, Silke Gloaguen, Borhane Slama, Aristoteles Giagounidis, Sophie Park, Regina Herbst, Benoit de Renzis

المصدر: Blood. 134:2998-2998

مصطلحات موضوعية: medicine.medical_specialty, Romiplostim, business.industry, Myelodysplastic syndromes, Immunology, Cell Biology, Hematology, medicine.disease, Lower risk, Biochemistry, Discontinuation, Platelet transfusion, Internal medicine, Cohort, medicine, business, Prospective cohort study, Adverse effect, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c249356cb38b529c57ce0bb39a1174c1Test
https://doi.org/10.1182/blood-2019-129047Test